A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 28, 2023

Primary Completion Date

March 30, 2025

Study Completion Date

April 30, 2025

Conditions
Sinusitis
Interventions
DRUG

300mg of TQH2722 injection

TQH2722 injection is a fully human monoclonal antibody that interfering with the signal cascade.

DRUG

600mg of TQH2722 injection

TQH2722 injection is a fully human monoclonal antibody that interfering with the signal cascade.

DRUG

TQH2722 injection matching placebo

Placebo without active substance.

Trial Locations (36)

30001

First Hospital of Shanxi Medical University, Taiyuan

100005

Beijing Hospital, Beijing

110001

The First Hospital of China Medical University, Shenyang

110004

Shengjing Hospital of China Medical University, Shenyang

110024

Central Hospital of Shenyang Medical College, Shenyang

130012

Jilin Province People's Hospital, Changchun

133002

The Affiliated Hospital of Yanbian University, Yanji

200000

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

210008

Nanjing Drum Tower Hospital, Nanjing

215006

The First Affiliated Hospital of Soochow University, Suzhou

241000

The First Affiliated Hospital of Wannan Medical College, Wuhu

250022

Shandong Second People's Hospital, Jinan

255036

Zibo Central Hospital, Zibo

261041

Weifang Second People's Hospital, Weifang

264000

Yantai Yuhuangding Hospital, Yantai

264400

Weihai Central Hospital, Weihai

317599

Wenling First People's Hospital, Taizhou

318000

Taizhou central hospital, Taizhou

417000

Loudi Central Hospital, Changsha

430023

Union Hospitalc, Tongji Medical College, Huazhong, University of Science and Technology, Wuhan

430060

Renmin Hospital of Wuhan University, Wuhan

450003

Henan Provincial People's Hospital, Zhengzhou

518035

The Second People's Hospital of Shenzhen, Shenzhen

522000

Jieyang People's Hospital, Jieyang

528000

Foshan First People's Hospital, Foshan

530021

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

550000

The Affiliated hospital of Guizhou Medical University, Guiyang

610000

Chengdu Second People's Hospital, Chengdu

610072

Sichuan Provincial People's Hospital, Chengdu

730000

Lanzhou University Second Hospital, Lanzhou

830011

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

Unknown

Beijing TongRen Hospital, Capital Medical University, Beijing

061000

Cangzhou Central Hospital, Cangzhou

050000

Hebei Medical University Third Hospital, Shijiazhuang

014040

Baotou Central Hospital, Baotou

010000

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

INDUSTRY

NCT06089278 - A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps. | Biotech Hunter | Biotech Hunter